ArticleDisease-Modifying Therapies in Progressive Multiple Sclerosis Author:Robert Shin, MDPublish date: June 30, 2022Key presentations at CMSC 2022 included use of BTK inhibitors in MS, results from the DISCOMS trial, and immune response of MS patients vaccinated ...Read More
